State Street Corp decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,601,590 shares of the company’s stock after selling 74,084 shares during the period. State Street Corp owned approximately 4.56% of Henry Schein worth $659,166,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also bought and sold shares of the company. Janus Henderson Group PLC boosted its position in shares of Henry Schein by 394.1% during the 2nd quarter. Janus Henderson Group PLC now owns 1,465,303 shares of the company’s stock valued at $268,173,000 after purchasing an additional 1,168,763 shares in the last quarter. Shelton Capital Management bought a new position in shares of Henry Schein during the 2nd quarter valued at about $1,139,000. Prudential PLC boosted its position in shares of Henry Schein by 18.8% during the 2nd quarter. Prudential PLC now owns 7,011 shares of the company’s stock valued at $1,283,000 after purchasing an additional 1,111 shares in the last quarter. AHL Partners LLP boosted its position in shares of Henry Schein by 38.4% during the 2nd quarter. AHL Partners LLP now owns 63,372 shares of the company’s stock valued at $11,598,000 after purchasing an additional 17,580 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in shares of Henry Schein by 3.3% during the 2nd quarter. Goldman Sachs Group Inc. now owns 424,592 shares of the company’s stock valued at $77,709,000 after purchasing an additional 13,386 shares in the last quarter. Institutional investors own 44.56% of the company’s stock.
HSIC has been the subject of several research reports. Zacks Investment Research lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Northcoast Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price objective for the company in a research note on Monday, August 7th. UBS AG reaffirmed a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. Piper Jaffray Companies raised shares of Henry Schein from a “neutral” rating to an “overweight” rating in a research note on Friday, September 15th. Finally, BidaskClub lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and seven have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $92.17.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://sportsperspectives.com/2017/10/11/state-street-corp-trims-stake-in-henry-schein-inc-hsic.html.
In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the sale, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.27% of the company’s stock.
Shares of Henry Schein, Inc. (HSIC) opened at 80.045 on Wednesday. The stock has a market capitalization of $12.66 billion, a price-to-earnings ratio of 23.391 and a beta of 1.08. Henry Schein, Inc. has a 52-week low of $73.12 and a 52-week high of $93.50. The stock has a 50 day moving average of $83.22 and a 200-day moving average of $87.48.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.86 by $0.02. The firm had revenue of $3.06 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.82 EPS. On average, equities research analysts predict that Henry Schein, Inc. will post $3.64 EPS for the current fiscal year.
Henry Schein announced that its Board of Directors has initiated a share repurchase program on Monday, September 18th that authorizes the company to buyback $400.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 6.3% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its stock is undervalued.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.